Project scope

To understand the unmet need with the current treatment landscape, value perception and pricing potential of a potential CAR-T therapy indicated for (2L and/or 3L+) DLBCL and 3L Follicular Lymphoma patients

Challenge

Our client wanted to understand the unmet need within the current treatment landscape for DLBCL and FL, alongside the value perception and pricing potential of a new CAR-T therapy

Solution

Conducted a market landscape assessment and extensive primary research to get detailed insights on:

• Satisfaction level with current treatment options and clinical benefits expected from new treatment options
• Clinical and economic value perception of a potential CAR-T product
• Expected price potential and coverage restrictions applicable to therapy after reimbursement

Results

• Enabled client to understand current treatment landscape and associated challenges with them
• Identified decision making drivers within new CAR-T therapies and understood reimbursement potential for the new product in development